As many as 1 in 4 cancers are driven by mutations in the SWI/SNF chromatin-remodeling complex, which controls access to DNA. A study led by St. Jude Children's Research Hospital recently identified ...
First author Hayden Malone, St. Jude Graduate School of Biomedical Sciences and corresponding author Charles W. M. Roberts, MD, PhD, Executive Vice President, and St. Jude Comprehensive Cancer Center ...
The FIPO23 trial: First-in-human phase I/II study of XON7 in advanced solids tumors. ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results